Stocks
Moderna, Inc.MRNA
NASDAQHealthcareBiotechnology$52.56-1.55%
A biotechnology company focused on developing messenger RNA (mRNA)–based medicines and vaccines, with products targeting infectious diseases, rare disorders, and oncology. Its COVID-19 vaccine drove a surge in revenue during the pandemic and remains a key commercial product while the firm advances a...
Market Cap: $20.8B52W Range: $22.28 – $59.55
Congressional Interest in Moderna, Inc. (MRNA)
6 members of Congress have disclosed 50 trades in Moderna, Inc. (MRNA), a Healthcare company. The buy/sell breakdown shows 18 purchases versus 31 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
6
Buys
18
Sells
31
Who in Congress Is Trading MRNA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-01-29 | Rohit Khanna | sell | $1K – $15K |
| 2026-01-23 | Rohit Khanna | buy | $1K – $15K |